{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-140810","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.248432+00:00","generated_at":"2026-05-19T07:50:49.297320+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Whitehawk Therapeutics shareholders elect three Class II directors at annual meeting","bullets":["Three Class II directors elected: Anupam Dalal (18.5M for, 5.0M withheld), Mohammad Hirmand (19.4M for, 4.2M withheld), David Lennon (19.4M for, 4.2M withheld).","Board size decreased from 10 to 9 directorships upon opening of polls.","Advisory vote on executive compensation passed: 18.9M for, 4.7M against, 14k abstentions.","Ratification of BDO USA as auditor for FY2025 approved with 28.1M for, 524k against, 101k abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-140810","json":"https://secwatch.observer/filing/0001193125-25-140810.json","markdown":"https://secwatch.observer/filing/0001193125-25-140810.md","text":"https://secwatch.observer/filing/0001193125-25-140810.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/0001193125-25-140810-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312525140810/d928055d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T07:50:49.297320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}